000950 重藥控股
按盤價 
6.170 -0.280 (-4.341%)
6.170 -0.280 (-4.341%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 3.356 | 2.511 | 5.713 | 9.303 | 10.778 |
| 總資產報酬率 ROA (%) | 0.572 | 0.435 | 1.035 | 1.782 | 2.183 |
| 投入資產回報率 ROIC (%) | 0.960 | 0.738 | 1.710 | 2.795 | 3.409 | 邊際利潤分析 |
| 銷售毛利率 (%) | 7.215 | 7.434 | 7.993 | 8.581 | 9.178 |
| 營業利潤率 (%) | 1.069 | 0.698 | 1.231 | 2.116 | 2.497 |
| 息稅前利潤/營業總收入 (%) | 1.954 | 2.038 | 2.893 | 3.784 | 4.267 |
| 淨利潤/營業總收入 (%) | 0.856 | 0.499 | 0.932 | 1.715 | 2.064 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 166.550 | 129.526 | 108.174 | 82.894 | 86.852 |
| 價值變動淨收益/利潤總額(%) | 21.163 | 73.422 | 32.878 | 20.079 | 27.183 |
| 營業外收支淨額/利潤總額(%) | -1.176 | -0.921 | 0.150 | 2.545 | 1.225 | 償債能力分析 |
| 流動比率 (X) | 1.233 | 1.303 | 1.272 | 1.198 | 1.303 |
| 速動比率 (X) | 1.019 | 1.077 | 1.072 | 1.004 | 1.112 |
| 資產負債率 (%) | 75.670 | 75.291 | 75.638 | 77.776 | 76.325 |
| 帶息債務/全部投入資本 (%) | 68.709 | 69.689 | 66.949 | 69.010 | 66.250 |
| 股東權益/帶息債務 (%) | 42.362 | 40.361 | 46.044 | 42.106 | 47.097 |
| 股東權益/負債合計 (%) | 22.554 | 22.579 | 23.358 | 23.946 | 25.890 |
| 利息保障倍數 (X) | 2.178 | 1.514 | 1.742 | 2.346 | 2.453 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 153.927 | 145.517 | 139.277 | 144.535 | 137.356 |
| 存貨周轉天數 (天) | 47.105 | 44.848 | 41.089 | 40.388 | 37.100 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 12/12/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
